Engineered CD4 T Cells for In Vivo Delivery of Therapeutic Proteins

Researchers addressed the challenge of achieving effective disease treatment with safe doses of complex biologics with otherwise short half-lives. They engineered CD4 T cells to express therapeutic proteins precisely at the disease site.